Published in Cancer Lett on August 16, 1995
Curcumin: from ancient medicine to current clinical trials. Cell Mol Life Sci (2008) 4.24
Detection of curcumin and its metabolites in hepatic tissue and portal blood of patients following oral administration. Br J Cancer (2004) 1.97
Curcumin induces proapoptotic effects against human melanoma cells and modulates the cellular response to immunotherapeutic cytokines. Mol Cancer Ther (2009) 1.04
Effects of luteolin and quercetin, inhibitors of tyrosine kinase, on cell growth and metastasis-associated properties in A431 cells overexpressing epidermal growth factor receptor. Br J Pharmacol (1999) 1.03
Inhibitory effect of curcumin on the invasion of rat ascites hepatoma cells in vitro and ex vivo. Cytotechnology (2001) 0.90
Biological and therapeutic activities, and anticancer properties of curcumin. Exp Ther Med (2015) 0.86
Botanicals for the prevention and treatment of cutaneous melanoma. Pigment Cell Melanoma Res (2011) 0.85
Red wine polyphenols for cancer prevention. Int J Mol Sci (2008) 0.83
Current research and development of chemotherapeutic agents for melanoma. Cancers (Basel) (2010) 0.81
Curcumin Inhibits Non-Small Cell Lung Cancer Cells Metastasis through the Adiponectin/NF-κb/MMPs Signaling Pathway. PLoS One (2015) 0.79
Effects of curcumin on global gene expression profiles in the highly invasive human breast carcinoma cell line MDA-MB 231: A gene network-based microarray analysis. Exp Ther Med (2012) 0.79
Inhibition of the STAT3 signaling pathway contributes to apigenin-mediated anti-metastatic effect in melanoma. Sci Rep (2016) 0.79
Effects of apigenin on steroidogenesis and steroidogenic acute regulatory gene expression in mouse Leydig cells. J Nutr Biochem (2011) 0.77
Chemoprevention of melanoma. Adv Pharmacol (2012) 0.76
Potential therapeutic targets of epithelial-mesenchymal transition in melanoma. Cancer Lett (2017) 0.75
Systematic and comprehensive investigation of the toxicity of curcuminoid‑essential oil complex: A bioavailable turmeric formulation. Mol Med Rep (2015) 0.75
Nanoformulations of curcumin: an emerging paradigm for improved remedial application. Oncotarget (2017) 0.75
Anti-tumour and antioxidant activity of natural curcuminoids. Cancer Lett (1995) 2.52
Anti-diabetic activity of Picrorrhiza kurroa extract. J Ethnopharmacol (1999) 1.89
Potential anticancer activity of turmeric (Curcuma longa). Cancer Lett (1985) 1.79
Immunomodulatory and antitumor activity of Piper longum Linn. and piperine. J Ethnopharmacol (2004) 1.48
Effect of oral curcumin administration on serum peroxides and cholesterol levels in human volunteers. Indian J Physiol Pharmacol (1992) 1.44
Cytotoxic and anti-tumour properties of certain taxa of Umbelliferae with special reference to Centella asiatica (L.) Urban. J Ethnopharmacol (1995) 1.31
sym-Homospermidine, a naturally occurring polyamine. Biochemistry (1971) 1.29
Anticancer and antioxidant activity of synthetic chalcones and related compounds. Cancer Lett (1995) 1.28
Effect of Emblica officinalis, Phyllanthus amarus and Picrorrhiza kurroa on N-nitrosodiethylamine induced hepatocarcinogenesis. Cancer Lett (1999) 1.27
Immunomodulatory activity of Withania somnifera. J Ethnopharmacol (2000) 1.22
Turmeric and curcumin as topical agents in cancer therapy. Tumori (1987) 1.19
Biochemistry of the hydroxyprolines. Adv Enzymol Relat Areas Mol Biol (1973) 1.17
The biosynthesis of cis-4-hydroxy-L-proline in sandal (Santalum album L.). Biochem J (1970) 1.10
Anti-metastatic activity of curcumin and catechin. Cancer Lett (1999) 1.08
Effect of Withania somnifera on DMBA induced carcinogenesis. J Ethnopharmacol (2001) 1.06
Inhibition of chemical carcinogenesis by berberine in rats and mice. J Pharm Pharmacol (2001) 1.06
Piperine is a potent inhibitor of nuclear factor-kappaB (NF-kappaB), c-Fos, CREB, ATF-2 and proinflammatory cytokine gene expression in B16F-10 melanoma cells. Int Immunopharmacol (2004) 1.04
Expression of vascular endothelial growth factor (VEGF) and VEGF receptors in tumor angiogenesis and malignancies. Integr Cancer Ther (2005) 1.03
Antioxidant activity of Tinospora cordifolia and its usefulness in the amelioration of cyclophosphamide induced toxicity. J Exp Clin Cancer Res (1997) 1.02
Antioxidant and anti-inflammatory activities of the plant Andrographis paniculata Nees. Immunopharmacol Immunotoxicol (2006) 1.01
Inhibition of lipid peroxidation and cholesterol levels in mice by curcumin. Indian J Physiol Pharmacol (1992) 1.00
Hepatoprotective activity of Emblica officinalis and Chyavanaprash. J Ethnopharmacol (2000) 1.00
Antitumour activity of Emblica officinalis. J Ethnopharmacol (2001) 0.98
Inhibition of liver fibrosis by ellagic acid. Indian J Physiol Pharmacol (1996) 0.98
Effect of naturally occurring triterpenoids glycyrrhizic acid, ursolic acid, oleanolic acid and nomilin on the immune system. Phytomedicine (2003) 0.98
Effect of piperine on the inhibition of lung metastasis induced B16F-10 melanoma cells in mice. Clin Exp Metastasis (2002) 0.98
Inhibition of chemical carcinogenesis by curcumin. J Ethnopharmacol (1989) 0.97
Clinical trial of certain ayurvedic medicines indicated in vitiligo. Anc Sci Life (1990) 0.97
Suppressive effect of cyclophosphamide-induced toxicity by Withania somnifera extract in mice. J Ethnopharmacol (1998) 0.95
Tumour reducing and anticarcinogenic activity of selected spices. Cancer Lett (1990) 0.95
Activation of cytotoxic T lymphocyte responses and attenuation of tumor growth in vivo by Andrographis paniculata extract and andrographolide. Immunopharmacol Immunotoxicol (2007) 0.94
Protective effect of food additives on aflatoxin-induced mutagenicity and hepatocarcinogenicity. Cancer Lett (1997) 0.94
Reversal of aflatoxin induced liver damage by turmeric and curcumin. Cancer Lett (1992) 0.94
Preparation and composition of alveolar extracellular matrix and incorporated basement membrane. Lung (1981) 0.93
Phyllanthus amarus extract administration increases the life span of rats with hepatocellular carcinoma. J Ethnopharmacol (2000) 0.93
Inhibition of tumor specific angiogenesis by amentoflavone. Biochemistry (Mosc) (2008) 0.91
Inhibition of tumour promotion in mice by eugenol. Indian J Physiol Pharmacol (1994) 0.91
Activation of prolyl hydroxylase in fibroblasts by ascorbic acid. Ann N Y Acad Sci (1975) 0.91
Effect of a preparation from Viscum album on tumor development in vitro and in mice. J Ethnopharmacol (1990) 0.90
Inhibition of inosinate dehydrogenase by metabolites of 2-beta-D-ribofuranosyl thiazole-4-carboxamide. Biochem Biophys Res Commun (1982) 0.90
Immunomodulatory activity of naturally occurring monoterpenes carvone, limonene, and perillic acid. Immunopharmacol Immunotoxicol (2003) 0.89
Chemoprotective activity of an extract of Phyllanthus amarus against cyclophosphamide induced toxicity in mice. Phytomedicine (2005) 0.89
Screening of 11 ferns for cytotoxic and antitumor potential with special reference to Pityrogramma calomelanos. J Ethnopharmacol (1991) 0.89
Antiangiogenic activity of Andrographis paniculata extract and andrographolide. Int Immunopharmacol (2006) 0.88
Effect of Withania somnifera on CTL activity. J Exp Clin Cancer Res (2002) 0.88
An activatable form of prolyl hydroxylase in fibrobalast extracts. Biochem Biophys Res Commun (1975) 0.88
Protective effect of curcumin, ellagic acid and bixin on radiation induced toxicity. Indian J Exp Biol (1996) 0.88
Effect of Tinospora cordifolia on the cytokine profile of angiogenesis-induced animals. Int Immunopharmacol (2004) 0.87
Inhibitory effect of a polysaccharide from Tinospora cordifolia on experimental metastasis. J Ethnopharmacol (2004) 0.87
Studies on the biosynthesis of sym-homospermidine in sandal (Santalum album L.). Biochem J (1972) 0.87
Antioxidant activity of brahma rasayana. Indian J Exp Biol (2001) 0.87
Immunomodulatory activity of curcumin. Immunol Invest (1999) 0.87
Immunomodulatory activity of Sulforaphane, a naturally occurring isothiocyanate from broccoli (Brassica oleracea). Phytomedicine (2006) 0.87
Effect of isoflavones genistein and daidzein in the inhibition of lung metastasis in mice induced by B16F-10 melanoma cells. Nutr Cancer (1998) 0.87
Protective effect of curcumin, ellagic acid and bixin on radiation induced genotoxicity. J Exp Clin Cancer Res (1998) 0.86
Myeloprotective effect of a non-toxic indigenous preparation Rasayana in cancer patients receiving chemotherapy and radiation therapy. A pilot study. J Exp Clin Cancer Res (1999) 0.86
Induction of apoptosis in mouse and human carcinoma cell lines by Emblica officinalis polyphenols and its effect on chemical carcinogenesis. J Exp Clin Cancer Res (2003) 0.86
Immunomodulatory activity of a peptide isolated from Viscum album extract (NSC 635 089). Immunol Invest (1992) 0.86
Effect of naturally occurring isothiocyanates in the inhibition of cyclophosphamide-induced urotoxicity. Phytomedicine (2005) 0.86
Effect of Withania somnifera on 20-methylcholanthrene induced fibrosarcoma. J Exp Clin Cancer Res (2000) 0.85
A preliminary study on antimetastatic activity of Thuja occidentalis L. in mice model. Immunopharmacol Immunotoxicol (2006) 0.84
Cytotoxicity of extracts of spices to cultured cells. Nutr Cancer (1988) 0.84
Augmentation of natural killer cell and antibody-dependent cellular cytotoxicity in BALB/c mice by sulforaphane, a naturally occurring isothiocyanate from broccoli through enhanced production of cytokines IL-2 and IFN-gamma. Immunopharmacol Immunotoxicol (2006) 0.84
Regulation of Caspase-3 and Bcl-2 Expression in Dalton's Lymphoma Ascites Cells by Abrin. Evid Based Complement Alternat Med (2007) 0.84
The isolation and characterization of gamma-L-glutamyl-S-(trans-1-propenyl)-L-cysteine sulfoxide from sandal (Santalum album L). An interesting occurrence of sulfoxide diastereoisomers in nature. Biochemistry (1974) 0.84
Isolation and identification of a tumour reducing component from mistletoe extract (Iscador). Cancer Lett (1988) 0.84
Effect of naturally occurring triterpenoids ursolic acid and glycyrrhizic acid on the cell-mediated immune responses of metastatic tumor-bearing animals. Immunopharmacol Immunotoxicol (2008) 0.84
Modulation of cell-mediated immune response in B16F-10 melanoma-induced metastatic tumor-bearing C57BL/6 mice by sulforaphane. Immunopharmacol Immunotoxicol (2007) 0.84
Anti-tumour studies of metal chelates of synthetic curcuminoids. J Exp Clin Cancer Res (2002) 0.83
Effect of "rasayanas", a herbal drug preparation on immune responses and its significance in cancer treatment. Indian J Exp Biol (1999) 0.83
Effect of brahma rasayana on antioxidant system after radiation. Indian J Exp Biol (2001) 0.83
Protective effect of Piper longum fruit ethanolic extract on radiation induced damages in mice: a preliminary study. Fitoterapia (2005) 0.83
Effect of Picrorrhiza kurroa extract on transplanted tumours and chemical carcinogenesis in mice. J Ethnopharmacol (2000) 0.83
Studies on the role of some synthetic curcuminoid derivatives in the inhibition of tumour specific angiogenesis. J Exp Clin Cancer Res (2003) 0.82
Effect of Withania somnifera on B16F-10 melanoma induced metastasis in mice. Phytother Res (2004) 0.82
Effect of piperine on the inhibition of nitric oxide (NO) and TNF-alpha production. Immunopharmacol Immunotoxicol (2003) 0.82
Anti-tumour and anti-oxidant activity of naturally occurring isothiocyanates. J Exp Clin Cancer Res (2003) 0.82
Alleviation of cyclophosphamide-induced urotoxicity by naturally occurring sulphur compounds. J Exp Clin Cancer Res (2002) 0.82
Effect of herbal preparation, brahma rasayana, in amelioration of radiation induced damage. Indian J Exp Biol (2000) 0.82
Effect of Withania somnifera on cell mediated immune responses in mice. J Exp Clin Cancer Res (2002) 0.82
Effect of Brahma Rasayana on antioxidant systems and cytokine levels in mice during cyclophosphamide administration. J Exp Clin Cancer Res (2001) 0.81
Effect of Biophytum sensitivum on cell-mediated immune response in mice. Immunopharmacol Immunotoxicol (2007) 0.81
Inhibition of N-nitrosodiethylamine-induced hepatocarcinogenesis by Picroliv. J Exp Clin Cancer Res (2000) 0.81
Effect of ascorbic acid on prolyl hydroxylase activity, collagen hydroxylation and collagen synthesis in human synovial cells in culture. Res Commun Chem Pathol Pharmacol (1979) 0.81
Modulation of natural killer cell activity, antibody-dependent cellular cytotoxicity, and antibody-dependent complement-mediated cytotoxicity by andrographolide in normal and Ehrlich ascites carcinoma-bearing mice. Integr Cancer Ther (2007) 0.81
Synthesis of type I and type III collagen by synovial cells in tissue culture derived from patients with rheumatoid arthritis, osteoarthritis, and normal individuals. Proc Soc Exp Biol Med (1980) 0.80